Consequences of COVID-19 for the musculoskeletal and peripheral nervous systems. Diagnosis of complications (literature review)

Abstract

COVID-19 disease does not only lead to impaired respiratory function. Post-COVID complications are multiple with the involvement of many body systems, including the musculoskeletal system and the peripheral nervous system. Diseases of the musculoskeletal system include myalgia, myositis, rhabdomyolysis, acute arthralgia, arthritis, bone osteoporosis. Damage to the peripheral nervous system caused by coronavirus infection includes plexopathy due to lying down, poly-neuropathy, Guillain–Barre syndrome. This descriptive literature review discusses the effects of COVID-19 on the musculoskeletal system and the peripheral nervous system of patients. Data are presented on the use of diagnostic tools such as computed tomography, magnetic resonance imaging, and ultrasound scans to detect pathology.

Keywords

COVID-19 / postcovid complications / musculoskeletal system / peripheral nerves / ultrasound diagnostics

References

[1] who.int [Internet]. Coronavirus Disease (COVID-19) Pandemic. World Health Organization; 2020 Oct 30 [cited 2022 Feb 10]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019

[2] who.int [Internet]. Coronavirus Disease (COVID-19) Pandemic. World Health Organization; 2020 Oct 30 [дата обращения: 10.02.2022]. Доступ по ссылке: https://www.who.int/emergencies/diseases/novel-coronavirus-2019

[3] Disser NP, De Micheli AJ, Schonk MM, et al. Musculoskeletal consequences of COVID-19. J Bone Joint Surg Am. 2020;102(14):1197–1204. doi: 10.2106/JBJS.20.00847

[4] Disser N.P., De Micheli A.J., Schonk M.M., et al. Musculoskeletal consequences of COVID-19 // J Bone Joint Surg Am. 2020. Vol. 102, N 14. P. 1197–1204. doi: 10.2106/JBJS.20.00847

[5] Ghannam M, Alshaer Q, Al-Chalabi M, et al. Neurological involvement of coronavirus disease 2019: a systematic review. J Neurol. 2020;267(11):3135–3153. doi: 10.1007/s00415-020-09990-2

[6] Ghannam M., Alshaer Q., Al-Chalabi M., et al. Neurological involvement of coronavirus disease 2019: a systematic review // J Neurol. 2020. Vol. 267, N 11. P. 3135–3153. doi: 10.1007/s00415-020-09990-2

[7] Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–690. doi: 10.1001/jamaneurol.2020.1127

[8] Mao L., Jin H., Wang M., et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China // JAMA Neurol. 2020. Vol. 77, N 6. P. 683–690. doi: 10.1001/jamaneurol.2020.1127

[9] Piotrowicz K, Gąsowski J, Michel JP, Veronese N. Post COVID 19 acute sarcopenia: physiopathology and management. Aging Clin Exp Res. 2021;33(10):2887–2898. doi: 10.1007/s40520-021-01942-8

[10] Piotrowicz K., Gąsowski J., Michel J.-P., Veronese N. Post COVID-19 acute sarcopenia: physiopathology and management // Aging Clin Exp Res. 2021. Vol. 33, N 10. P. 2887–2898. doi: 10.1007/s40520-021-01942-8

[11] Heydari K, Lotfi P, Shadmehri N, et al. Clinical and paraclinical characteristics of COVID-19 patients: a systematic review and meta-analysis. Tabari Biomed Stu Res J. 2022;4(1):30–47. doi: 10.18502/tbsrj.v4i1.8772

[12] Heydari K., Lotfi P., Shadmehri N., et al. Clinical and paraclinical characteristics of COVID-19 patients: a systematic review and meta-analysis // Tabari Biomed Stu Res J. 2022. Vol. 4, N 1. P. 30–47. doi: 10.18502/tbsrj.v4i1.8772

[13] Nasiri MJ, Haddadi S, Tahvildari A, et al. COVID-19 clinical characteristics, and sex-specific risk of mortality: systematic review and meta-analysis. Front Med (Lausanne). 2020;7:459. doi: 10.3389/fmed.2020.00459

[14] Nasiri M.J., Haddadi S., Tahvildari A., et al. COVID-19 clinical characteristics, and sex-specific risk of mortality: systematic review and meta-analysis // Front Med (Lausanne). 2020. Vol. 7. P. 459. doi: 10.3389/fmed.2020.00459

[15] Ciaffi J, Meliconi R, Ruscitti P, et al. Rheumatic manifestations of COVID-19: a systematic review and meta-analysis. BMC Rheumatol. 2020;4:65. doi: 10.1186/s41927-020-00165-0

[16] Ciaffi J., Meliconi R., Ruscitti P., et al. Rheumatic manifestations of COVID-19: a systematic review and meta-analysis // BMC Rheumatol. 2020. Vol. 4. P. 65. doi: 10.1186/s41927-020-00165-0

[17] Ramani SL, Samet J, Franz CK, et al. Musculoskeletal involvement of COVID-19: review of imaging. Skeletal Radiol. 2021;50(9):1763–1773. doi: 10.1007/s00256-021-03734-7

[18] Ramani S.L., Samet J., Franz C.K., et al. Musculoskeletal involvement of COVID-19: review of imaging // Skeletal Radiol. 2021. Vol. 50, N 9. P. 1763–1773. doi: 10.1007/s00256-021-03734-7

[19] Hong N, Du XK. Avascular necrosis of bone in severe acute respiratory syndrome. Clin Radiol. 2004;59(7):602–608. doi: 10.1016/j.crad.2003.12.008

[20] Hong N., Du X.K. Avascular necrosis of bone in severe acute respiratory syndrome // Clin Radiol. 2004. Vol. 59, N 7. P. 602–608. doi: 10.1016/j.crad.2003.12.008

[21] Lippi G, Wong J, Henry BM. Myalgia may not be assotiated with severity of coronavirus disease 2019 (COVID-19). World J Emerg Med. 2020;11(3):193–194. doi: 10.5847/wjem.j.1920-8642.2020.03.013

[22] Lippi G., Wong J., Henry B.M. Myalgia may not be assotiated with severity of coronavirus disease 2019 (COVID-19) // World J Emerg Med. 2020. Vol. 11, N 3. P. 193–194. doi: 10.5847/wjem.j.1920-8642.2020.03.013

[23] Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi: 10.1001/jama.2020.1585

[24] Wang D., Hu B., Hu C., et al. Clinical characteristics of 138 hospitalized patients with 2019 coronavirus-infected pneumonia in Wuhan, China // JAMA. 2020. Vol. 323, N 11. P. 1061–1069. doi: 10.1001/jama.2020.1585

[25] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5

[26] Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China // Lancet. 2020. Vol. 395, N 10223. P. 497–506. doi: 10.1016/S0140-6736(20)30183-5

[27] Li LQ, Huang T, Wang YQ, et al. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virel. 2020;92(6):577–583. doi: 10.1002/jmv.25757

[28] Li L.Q., Huang T., Wang Y.Q., et al. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis // J Med Virel. 2020. Vol. 92, N 6. P. 577–583. doi: 10.1002/jmv.25757

[29] Lechien JR, Chiesa-Estomba CM, Place S, et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 2020;288(3):335–344. doi: 10.1111/joim.13089

[30] Lechien J.R., Chiesa-Estomba C.M., Place S., et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019 // J Intern Med. 2020. Vol. 288, N 3. P. 335–344. doi: 10.1111/joim.13089

[31] Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395(10239):1763–1770. doi: 10.1016/S0140-6736(20)31189-2

[32] Cummings M.J., Baldwin M.R., Abrams D., et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study // Lancet. 2020. Vol. 395, N 10239. P. 1763–1770. doi: 10.1016/S0140-6736(20)31189-2

[33] Zhu J, Zhong Z, Ji P, et al. Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis. Fam Med Community Health. 2020;8(2):e000466. doi: 10.1136/fmch-2020-000406 Erratum in: Correction: Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis. Fam Med Community Health. 2020;8(2):e000406corr1. doi: 10.1136/fmch-2020-000406corr1

[34] Zhu J., Zhong Z., Ji P., et al. Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis // Fam Med Community Health. 2020. Vol. 8, N 2. P. e000466. doi: 10.1136/fmch-2020-000406 Erratum in: Correction: Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis // Fam Med Community Health. 2020. Vol. 8, N 2. P. e000406corr1. doi: 10.1136/fmch-2020-000406corr1

[35] Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–232. doi: 10.1016/S0140-6736(20)32656-8

[36] Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study // Lancet. 2021. Vol. 397, N 10270. P. 220–232. doi: 10.1016/S0140-6736(20)32656-8

[37] de Andrade-Junior MC, de Salles IC, de Brito CM, et al. Skeletal muscle wasting and functional impartment in intensive care patients with severe COVID-19. Front Physiol. 2021;12:640973. doi: 10.3389/fphys.2021.640973

[38] de Andrade-Junior M.C., de Salles I.C., de Brito C.M., et al. Skeletal muscle wasting and functional impartment in intensive care patients with severe COVID-19 // Front Physiol. 2021. Vol. 12. P. 640973. doi: 10.3389/fphys.2021.640973

[39] Soares MN, Eggelbusch M, Naddaf E, et al. Skeletal muscle alterations in patients with acute Covid-19 and post-acute secular of Covid-19. J Cachexia Sarcopenia Muscle. 2022;13(1):11–22. doi: 10.1002/jcsm.12896

[40] Soares M.N., Eggelbusch M., Naddaf E., et al. Skeletal muscle alterations in patients with acute Covid-19 and post-acute secular of Covid-19 // J Cachexia Sarcopenia Muscle. 2022. Vol. 13, N 1. P. 11–22. doi: 10.1002/jcsm.12896

[41] Paneroni M, Simonelli C, Saleri M, et al. Muscle strength and physical performance in patients without previous disabilities recovering from COVID-19 pneumonia. Am J Phys Med Rehabil. 2021;100(2):105–109. doi: 10.1097/PHM.0000000000001641

[42] Paneroni M., Simonelli C., Saleri M., et al. Muscle strength and physical performance in patients without previous disabilities recovering from COVID-19 pneumonia // Am J Phys Med Rehabil. 2021. Vol. 100, N 2. P. 105–109. doi: 10.1097/PHM.0000000000001641

[43] Leung TW, Wong KS, Hui AC, et al. Myopathic changes associated with severe acute respiratory syndrome: a postmortem case series. Arch Neurol. 2005;62(7):1113–1117. doi: 10.1001/archneur.62.7.1113

[44] Leung T.W., Wong K.S., Hui A.C., et al. Myopathic changes associated with severe acute respiratory syndrome: a postmortem case series // Arch Neurol. 2005. Vol. 62, N 7. P. 1113–1117. doi: 10.1001/archneur.62.7.1113

[45] Mehan WA, Yoon BC, Lang M, et al. Paraspinal myositis in patients with COVID-19 infection. AJNR Am J Neuroradiol. 2020;41(10):1949–1952. doi: 10.3174/ajnr.A6711

[46] Mehan W.A., Yoon B.C., Lang M., et al. Paraspinal myositis in patients with COVID-19 infection // AJNR Am J Neuroradiol. 2020. Vol. 41, N 10. P. 1949–1952. doi: 10.3174/ajnr.A6711

[47] Beydon M, Chevalier K, Al Tabaa O, et al. Myositis is a manifestation of SARS-CoV-2. Ann Rheum Dis. 2021;80:e42. doi: 10.1136/annrheumdis-2020-217573

[48] Beydon M., Chevalier K., Al Tabaa O., et al. Myositis is a manifestation of SARS-CoV-2 // Ann Rheum Dis. 2021. Vol. 80. P. e42. doi: 10.1136/annrheumdis-2020-217573

[49] Zhang H, Charmchi Z, Seidman RJ, et al. COVID-19 associated myositis with severe proximal and bulbar weakness. Muscle Nerve. 2020;62(3):E57–E60. doi: 10.1002/mus.2700

[50] Zhang H., Charmchi Z., Seidman R.J., et al. COVID-19 associated myositis with severe proximal and bulbar weakness // Muscle Nerve. 2020. Vol. 62, N 3. P. E57–E60. doi: 10.1002/mus.2700

[51] Hoong CW, Amin MN, Tan TC, Lee JE. Viral arthralgia a new manifestation of COVID-19 infection? Int J Infect Dis. 2021;104:363–369. doi: 10.1016/j.ijid.2021.01.031

[52] Hoong C.W., Amin M.N., Tan T.C., Lee J.E. Viral arthralgia a new manifestation of COVID-19 infection? // Int J Infect Dis. 2021. Vol. 104. P. 363–369. doi: 10.1016/j.ijid.2021.01.031

[53] Gasparotto M, Framba V, Piovella C, et al. Post-COVID-19 arthritis: a case report and literature review. Clin Rheumatol. 2021;40(8):3357–3362. doi: 10.1007/s10067-020-05550-1

[54] Gasparotto M., Framba V., Piovella C., et al. Post-COVID-19 arthritis: a case report and literature review // Clin Rheumatol. 2021. Vol. 40, N 8. P. 3357–3362. doi: 10.1007/s10067-020-05550-1

[55] Parisi S, Borrelli R, Bianchi S, Fusaro E. Viral arthritis and COVID-19. Lancet Rheumatol. 2020;2(11):e655–e657. doi: 10.1016/S2665-9913(20)30348-9

[56] Parisi S., Borrelli R., Bianchi S., Fusaro E. Viral arthritis and COVID-19 // Lancet Rheumatol. 2020. Vol. 2, N 11. P. e655–e657. doi: 10.1016/S2665-9913(20)30348-9

[57] Zhang B, Zhang S. Corticosteroid-induced osteonecrosis in COVID-19: a case for caution. J Bone Miner Res. 2020;35(9):1828–1829. doi: 10.1002/jbmr.4136

[58] Zhang B., Zhang S. Corticosteroid-induced osteonecrosis in COVID-19: a case for caution // J Bone Miner Res. 2020. Vol. 35, N 9. P. 1828–1829. doi: 10.1002/jbmr.4136

[59] Napoli N, Elderkin AL, Kiel DP, Khosla S. Managing fragility fractures during the COVID-19 pandemic. Nat Rev Endocrinol. 2020;16(9):467–468. doi: 10.1038/s41574-020-0379-z

[60] Napoli N., Elderkin A.L., Kiel D.P., Khosla S. Managing fragility fractures during the COVID-19 pandemic // Nat Rev Endocrinol. 2020. Vol. 16, N 9. P. 467–468. doi: 10.1038/s41574-020-0379-z

[61] Agarwala SR, Vijayvargiya M, Pandey P. Avascular necrosis as a part of ‘long COVID-19’. BMJ Case Rep. 2021;14(7):e242101. doi: 10.1136/bcr-2021-242101

[62] Agarwala S.R., Vijayvargiya M., Pandey P. Avascular necrosis as a part of ‘long COVID-19’ // BMJ Case Rep. 2021. Vol. 14, N 7. P. e242101. doi: 10.1136/bcr-2021-242101

[63] Sulewski A, Sieroń D, Szyluk K, et al. Avascular necrosis bone complication after COVID-19 infection: preliminary results. Medicina (Kaunas). 2021;57(12):1311. doi: 10.3390/medicina57121311

[64] Sulewski A., Sieroń D., Szyluk K., et al. Avascular necrosis bone complication after COVID-19 infection: preliminary results // Medicina (Kaunas). 2021. Vol. 57, N 12. P. 1311. doi: 10.3390/medicina57121311

[65] Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92(6):552–555. doi: 10.1002/jmv.25728

[66] Li Y.C., Bai W.Z., Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients // J Med Virol. 2020. Vol. 92, N 6. P. 552–555. doi: 10.1002/jmv.25728

[67] Lahiri D, Ardila A. COVID-19 Pandemic: A Neurological Perspective. Cureus. 2020;12(4):e7889. doi: 10.7759/cureus.7889

[68] Lahiri D., Ardila A. COVID-19 Pandemic: A Neurological Perspective. Cureus 2020;12(4):e7889. doi: 10.7759/cureus.7889

[69] Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368:m606. doi: 10.1136/bmj.m606

[70] Xu X.W., Wu X.X., Jiang X.G., et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-CoV-2) outside of Wuhan, China: retrospective case series // BMJ. 2020. Vol. 368. P. m606. doi: 10.1136/bmj.m606

[71] Katona I, Weis J. Diseases of the peripheral nerves. Handb Clin Neurol. 2017;145:453–474. doi: 10.1016/B978-0-12-802395-2.00031-6

[72] Katona I., Weis J. Diseases of the peripheral nerves // Handb Clin Neurol. 2017. Vol. 145. P. 453–474. doi: 10.1016/B978-0-12-802395-2.00031-6

[73] Montalvan V, Lee J, Bueso T, et al. Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review. Clin Neurol Neurosurg. 2020;194:105921. doi: 10.1016/j.clineuro.2020.105921

[74] Montalvan V., Lee J., Bueso T., et al. Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review // Clin Neurol Neurosurg. 2020. Vol. 194. P. 105921. doi: 10.1016/j.clineuro.2020.105921

[75] Sindic CJ. Infectious neuropathies. Curr Opin Neurol. 2013;26(5):510–515. doi: 10.1097/WCO.0b013e328364c036

[76] Sindic C.J. Infectious neuropathies // Curr Opin Neurol. 2013. Vol. 26, N 5. P. 510–515. doi: 10.1097/WCO.0b013e328364c036

[77] Selitskii MM, Ponomarev VV, Vist EV, et al. Guillain-Barré syndrome, associated with COVID-19. Lechebnoe delo: nauchno-prakticheskii terapevticheskii zhurnal. 2021;(3):41–47. (In Russ).

[78] Селицкий М.М., Пономарев В.В., Вист Э.В., и др. Синдром Гийена-Барре, ассоциированный с COVID-19 // Лечебное дело: научно-практический терапевтический журнал. 2021. № 3. С. 41–47.

[79] Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci. 2020;76:233–235. doi: 10.1016/j.jocn.2020.04.062

[80] Sedaghat Z., Karimi N. Guillain Barre syndrome associated with COVID-19 infection: a case report // J Clin Neurosci. 2020. Vol. 76. P. 233–235. doi: 10.1016/j.jocn.2020.04.062

[81] Chaikovskaya AD, Ivanova AD, Ternovykh IK, et al. Guillain-Barré syndrome during the COVID-19 infection. Sovremennye problemy nauki i obrazovaniya. 2020;(4):164. (In Russ). doi: 10.17513/spno.29950

[82] Чайковская А.Д., Иванова А.Д., Терновых И.К., и др. Синдром Гийена-Барре на фоне инфекции COVID-19 // Современные проблемы науки и образования. 2020. № 4. C. 164. doi: 10.17513/spno.29950

[83] Fernandoz CE, Franz CK, Ko JH, et al. Imaging review of peripheral nerves injuries in COVID-19. Radiology. 2021;298(3):E117–E130. doi: 10.1148/radiol.2020203116

[84] Fernandoz C.E., Franz C.K., Ko J.H., et al. Imaging review of peripheral nerves injuries in COVID-19 // Radiology. 2021. Vol. 298, N 3. P. E117–E130. doi: 10.1148/radiol.2020203116

[85] Mitry MA, Collins LK, Kazam JJ, et al. Parsonage-Turner syndrome associated with SARS-CoV2 (COVID-19) infection. Clin Imag-ing. 2021;72:8–10. doi: 10.1016/j.clinimag.2020.11.017

[86] Mitry M.A., Collins L.K., Kazam J.J., et al. Parsonage-Turner syndrome associated with SARS-CoV2 (COVID-19) infection // Clin Imaging. 2021. Vol. 72. P. 8–10. doi: 10.1016/j.clinimag.2020.11.017

[87] Voss TG, Stewart CM. Parsonage-Turner syndrome after COVID-19 infection. JSES Rev Rep Tech. 2022;2(2):182–185. doi: 10.1016/j.xrrt.2021.12.004

[88] Voss T.G., Stewart C.M. Parsonage-Turner syndrome after COVID-19 infection // JSES Rev Rep Tech. 2022. Vol. 2, N 2. P. 182–185. doi: 10.1016/j.xrrt.2021.12.004

[89] Kamel I, Barnette R. Positioning patients for spine surgery: Avoiding uncommon position-related complications. World J Orthop. 2014;5(4):425–443. doi: 10.5312/wjo.v5.i4.425

[90] Kamel I., Barnette R. Positioning patients for spine surgery: Avoiding uncommon position-related complications // World J Orthop. 2014. Vol. 5, N 4. P. 425–443. doi: 10.5312/wjo.v5.i4.425

[91] Winfree CJ, Kline DG. Intraoperative positioning nerve injuries. Surg Neurol. 2005;63(1):5–18; discussion 18. doi: 10.1016/j.surneu.2004.03.024

[92] Winfree C.J., Kline D.G. Intraoperative positioning nerve injuries // Surg Neurol. 2005. Vol. 63, N 1. P. 5–18; discussion 18. doi: 10.1016/j.surneu.2004.03.024

[93] Abdelnour L, Eltahir Abdalla M, Babiker S. COVID-19 infection presenting as motor peripheral neuropathy. J Formos Med Assoc. 2020;119(6):1119–1120. doi: 10.1016/j.jfma.2020.04.024

[94] Abdelnour L., Eltahir Abdalla M., Babiker S. COVID-19 infection presenting as motor peripheral neuropathy // J Formos Med Assoc. 2020. Vol. 119, N 6. P. 1119–1120. doi: 10.1016/j.jfma.2020.04.024

[95] Malik GR, Wolfe AR, Soriano R, et al. Injury-prone: peripheral nerve injuries associated with prone positioning for COVID-19-related acute respiratory distress syndrome. Br J Anaesth. 2020;125(6):e478–e480. doi: 10.1016/j.bja.2020.08.045

[96] Malik G.R., Wolfe A.R., Soriano R., et al. Injury-prone: peripheral nerve injuries associated with prone positioning for COVID-19-related acute respiratory distress syndrome // Br J Anaesth. 2020. Vol. 125, N 6. P. e478–e480. doi: 10.1016/j.bja.2020.08.045

[97] Le MQ, Rosales R, Shapiro LT, Huang LY. The down side of prone positioning: the case of a COVID-19 survivor. Am J Phys Med Rehabil. 2020;99(10):870–872. doi: 10.1097/PHM.0000000000001530

[98] Le M.Q., Rosales R., Shapiro L.T., Huang L.Y. The down side of prone positioning: the case of a COVID-19 survivor // Am J Phys Med Rehabil. 2020. Vol. 99, N 10. P. 870–872. doi: 10.1097/PHM.0000000000001530

[99] Needham E, Newcombe V, Michell A, et al. Mononeuritis multiplex: an unexpectedly common feature of severe COVID-19. J Neurol. 2021;268(8):2685–2689. doi: 10.1007/s00415-020-10321-8

[100] Needham E., Newcombe V., Michell A., et al. Mononeuritis multiplex: an unexpectedly common feature of severe COVID-19 // J Neurol. 2021. Vol. 268, N 8. P. 2685–2689. doi: 10.1007/s00415-020-10321-8

[101] Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol. 2011;10(10):931–941. doi: 10.1016/S1474-4422(11)70178-8

[102] Latronico N., Bolton C.F. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis // Lancet Neurol. 2011. Vol. 10, N 10. P. 931–941. doi: 10.1016/S1474-4422(11)70178-8

[103] Al-Ani F, Chehade S, Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res. 2020;192:152–160. doi: 10.1016/j.thromres.2020.05.039

[104] Al-Ani F., Chehade S., Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review // Thromb Res. 2020. Vol. 192. P. 152–160. doi: 10.1016/j.thromres.2020.05.039

RIGHTS & PERMISSIONS

Matveeva N.Y., Makarova E.V., Eskin N.A., Sokolova T.V.